Plasma Amyloid Concentration in Alzheimer’s Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer’s Disease Cases from Controls

BACKGROUND: Collection of cerebrospinal fluid (CSF) for measurement of amyloid-β (Aβ) species is a gold standard in Alzheimer’s disease (AD) diagnosis, but has risks. Thus, establishing a low-risk blood Aβ test with high AD sensitivity and specificity is of outmost interest. OBJECTIVE: We evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Feinkohl, Insa, Schipke, Carola G., Kruppa, Jochen, Menne, Felix, Winterer, Georg, Pischon, Tobias, Peters, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242850/
https://www.ncbi.nlm.nih.gov/pubmed/32176645
http://dx.doi.org/10.3233/JAD-200046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242850/
https://www.ncbi.nlm.nih.gov/pubmed/32176645
http://dx.doi.org/10.3233/JAD-200046

Ejemplares similares